Aristotle University Of Thessaloniki (AUTH)
Επίδραση της επλερενόνης και της ραμιπρίλης σε πειραματικό μοντέλο διαβητικής νεφροπάθειας
Abstract
dc:descriptionWe studied the effect of the combined treatment with an angiotensin converting enzyme inhibitor (ramipril) and eplerenone, compared with ramipril alone in the streptozocin-induced diabetic rat. Wistar rats were divided into four groups: non diabetic controls, streptozocin-treated diabetic rats (50 mg/kg), diabetic rats receiving ramipril (1 mg/kg), and diabetic rats treated with the combination of ramipril (1 mg/kg) and eplerenone (100 mg/kg) for 8 weeks. Our model produces early stage diabetic nephropathy. Diabetic rats developed polyuria, proteinuria, hyperfiltration (assessed by creatinine clearance), and histopathological evidence of renal injury, including glomerular hypertrophy and mesangial expansion. Ramipril and to a lesser extent ramipril combined with eplerenone reduced proteinuria. Both treatment approaches prevented glomerular hypertrophy. Addition of eplerenone to ramipril prevented glomerular hyperfiltration. A decrease in nitric oxide levels was detected in the cortex of diabetic rats that is reversed by combined treatment with eplerenone and ramipril but not with ramipril alone. Eplerenone in addition to an angiotensin converting enzyme inhibitor or an angiotensin receptor blocker may provide more complete interruption of the renin angiotensin aldosterone system and may be helpful in slowing the nephropathy progression. Clinical trials testing eplerenone at an early stage of diabetic nephropathy are eagerly awaited.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2011
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Mavrakanas, Thomas
- Μαυρακάνας, Θωμάς
Subjects
dc:subject × 14Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/26073